NCT03251495View on ClinicalTrials.gov

Immunologic Responses to a Live Attenuated Oral Cholera Vaccine

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 29, 2017

Primary Completion Date

December 10, 2024

Study Completion Date

December 31, 2025

Conditions
Cholera
Interventions
DRUG

Vaxchora

Vaxchora is a live attenuated cholera vaccine that provides immunity against V. cholerae serogroup O1. Participants will receive one single oral dose of 100 mL.

Trial Locations (1)

30030

The Hope Clinic of Emory University, Atlanta

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Emory University

OTHER